Real-world effectiveness of immune checkpoint inhibitors and BRAF/ MEK inhibitors among veteran patients with cutaneous melanoma

Daniel Y. Kim,Susan M. Swetter,Linden Huhmann,Matthew P. Dizon,Jacqueline M. Ferguson,Thomas F. Osborne, Allyson C. Spence, Amina Ziad,Nathanael Fillmore,Rebecca I. Hartman

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY（2024）

引用 0|浏览2

暂无评分

关键词

adjuvant,BRAF,cutaneous,cobimeti- nib,dabrafenib,ICI,immune checkpoint inhib- itors,ipilimumab,MEK,melanoma,metastatic,nivolumab,pembrolizumab,real-world,stage III,stage IV,systemic,targeted therapies,VA,vemur- afenib,veteran

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要